AU2001261732A1 - Composition for delivery of compounds to cells - Google Patents
Composition for delivery of compounds to cellsInfo
- Publication number
- AU2001261732A1 AU2001261732A1 AU2001261732A AU6173201A AU2001261732A1 AU 2001261732 A1 AU2001261732 A1 AU 2001261732A1 AU 2001261732 A AU2001261732 A AU 2001261732A AU 6173201 A AU6173201 A AU 6173201A AU 2001261732 A1 AU2001261732 A1 AU 2001261732A1
- Authority
- AU
- Australia
- Prior art keywords
- delivery
- cells
- compounds
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20600200P | 2000-05-19 | 2000-05-19 | |
US60/206,002 | 2000-05-19 | ||
US28512101P | 2001-04-20 | 2001-04-20 | |
US60/285,121 | 2001-04-20 | ||
PCT/US2001/016015 WO2001089579A2 (en) | 2000-05-19 | 2001-05-19 | Composition for delivery of compounds to cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001261732A1 true AU2001261732A1 (en) | 2001-12-03 |
Family
ID=26900956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001261732A Abandoned AU2001261732A1 (en) | 2000-05-19 | 2001-05-19 | Composition for delivery of compounds to cells |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020115216A1 (en) |
EP (1) | EP1286699A2 (en) |
AU (1) | AU2001261732A1 (en) |
WO (1) | WO2001089579A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2280997C (en) | 1997-03-11 | 2013-05-28 | Perry B. Hackett | Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
US7160682B2 (en) | 1998-11-13 | 2007-01-09 | Regents Of The University Of Minnesota | Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell |
US7262056B2 (en) * | 2001-11-08 | 2007-08-28 | Mirus Bio Corporation | Enhancing intermolecular integration of nucleic acids using integrator complexes |
US7824910B2 (en) * | 2001-11-29 | 2010-11-02 | Nippon Shokubai Co., Ltd. | Method of transducing a protein into cells |
AU2003231048A1 (en) * | 2002-04-22 | 2003-11-03 | Regents Of The University Of Minnesota | Transposon system and methods of use |
US20060026699A1 (en) * | 2004-06-04 | 2006-02-02 | Largaespada David A | Methods and compositions for identification of genomic sequences |
JP2011514423A (en) * | 2008-03-14 | 2011-05-06 | エーゲン、インコーポレイテッド | Biodegradable crosslinked branched poly (alkyleneimine) |
EP2731429A4 (en) * | 2011-07-15 | 2015-03-04 | Univ Georgia | Compounds, methods of making, and methods of use |
WO2016036960A1 (en) | 2014-09-03 | 2016-03-10 | Genesegues, Inc. | Therapeutic nanoparticles and related compositions, methods and systems |
US10456452B2 (en) | 2015-07-02 | 2019-10-29 | Poseida Therapeutics, Inc. | Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles |
US20170000743A1 (en) | 2015-07-02 | 2017-01-05 | Vindico NanoBio Technology Inc. | Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles |
ES2865481T3 (en) | 2016-04-29 | 2021-10-15 | Poseida Therapeutics Inc | Poly (histidine) -based micelles for complexation and delivery of proteins and nucleic acids |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0666923A1 (en) * | 1991-09-05 | 1995-08-16 | The University Of Connecticut | Targeted delivery of poly- or oligonucleotides to cells |
CA2135295A1 (en) * | 1992-06-17 | 1993-12-23 | Chu Jung | Arabinogalactan derivatives and uses thereof |
US5948681A (en) * | 1996-08-14 | 1999-09-07 | Children's Hospital Of Philadelphia | Non-viral vehicles for use in gene transfer |
JP2001523450A (en) * | 1997-11-13 | 2001-11-27 | リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ | Nucleic acid transfer vector for introducing nucleic acid into cell DNA |
CA2329147A1 (en) * | 1998-05-20 | 1999-11-25 | Feng Liu | A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier |
-
2001
- 2001-05-19 AU AU2001261732A patent/AU2001261732A1/en not_active Abandoned
- 2001-05-19 US US09/861,014 patent/US20020115216A1/en not_active Abandoned
- 2001-05-19 EP EP01935657A patent/EP1286699A2/en not_active Withdrawn
- 2001-05-19 WO PCT/US2001/016015 patent/WO2001089579A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1286699A2 (en) | 2003-03-05 |
US20020115216A1 (en) | 2002-08-22 |
WO2001089579A2 (en) | 2001-11-29 |
WO2001089579A3 (en) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273034A1 (en) | Composition for delivery of hematopoietic growth factor | |
AU7719100A (en) | Compositions of tocol-soluble therapeutics | |
AU2001280767A1 (en) | Peptide-mediated delivery of molecules into cells | |
AU2002210993A1 (en) | Medicinal compositions for concominant use as anticancer agents | |
AU2001259846A1 (en) | Methods and compositions for enhancing the delivery of a nucleic acid to a cell | |
AU5033800A (en) | Ascorbic acid derivative composition for increasing cell renewal rate | |
AU1998100A (en) | Novel curative for anaerobic adhesive compositions | |
AU2093101A (en) | Compositions for efficient release of active ingredients | |
AU2002218751A1 (en) | Stable radiopharmaceutical compositions | |
AU2002220533A1 (en) | Dermal anti-inflammatory composition | |
AU2001282301A1 (en) | Fuel composition | |
HK1059558A1 (en) | Topical compositions containing prostaglandin e1 | |
AU2001233691A1 (en) | Antiperspirant compositions | |
AU2001258677A1 (en) | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them | |
AU2001285790A1 (en) | Antiperspirant compositions | |
AU2001261732A1 (en) | Composition for delivery of compounds to cells | |
AU2001268131A1 (en) | Stabilized compositions containing oxygen-labile active agents | |
AU2001290239A1 (en) | Medicinal composition | |
AU2002256304A1 (en) | Compositions for delivery of compounds to cells and methods of use | |
AU5622300A (en) | Stable l-ascorbic acid composition | |
AU752953C (en) | Adding pharmaceutically active compounds to substrates | |
AU2001285325A1 (en) | Use of threo-methylphenidate compounds to enhance memory | |
AU2003205717A1 (en) | New medicinal compositions containing heterocyclical compounds in addition to anticholinergics | |
AU3317200A (en) | Antiperspirant compositions containing isopropyl glycerol ether | |
AU2001271391A1 (en) | Novel compositions for use as electrode materials and for hydrogen production |